Clinical Trials Browser

Phase NA × Recurrence × Interleukin-2 × Clear all

NCT01517347 2016-10-24

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Phase NA Terminated

Other hematologic neoplasm

Leukemia, Recurrence